11
Participants
Start Date
January 31, 2004
Primary Completion Date
May 31, 2004
Study Completion Date
October 31, 2008
Intralipid +/- Omegaven
"Intralipid®: the 500 ml 20% Intralipid will be infused during a hyperinsulinemic clamp. Infusion rate will increase from 50 to 100 ml/hour the first 30 min and then continue at 100 ml/hour for the next 210 min, infusion duration 240 min (4 hours) in all.~Intralipid® + Omegaven®: In the 500 ml 20% Intralipid 100 ml will be replaced by 100 ml 10% Omegaven and infused during the hyperinsulinemic clamp as described for Intralipid only. Heparin (0.4 U/kg/min) will be added to both lipid emulsions.~Content of marine n-3 fatty acids in 100 ml Omegaven will be 1.25-2.82 g EPA and 1.44-3.09 g DHA (seasoning variations of n-3 fatty acids in fish oil)."
Department of Medicine, Division of Endocrinology, St. Olavs Hospital, Trondheim
Collaborators (1)
Norwegian University of Science and Technology
OTHER
Norwegian Foundation for Health and Rehabilitation
OTHER
Novo Nordisk A/S
INDUSTRY
Norwegian Diabetes Association
OTHER
St. Olavs Hospital
OTHER